NSC |
Compound |
Enrichment |
Correlation |
NSC 128687 |
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) |
0.00126952303154153 |
0.30418728 |
NSC 258812 |
N,N-Dimethyldaunomycin hydrochloride |
0.00126952303154153 |
0.52152555 |
NSC 692582 |
Null |
0.00126952303154154 |
0.2908561 |
NSC 703462 |
Null |
0.00126952303154154 |
0.22559474 |
NSC 733752 |
Null |
0.00126952303154154 |
0.43632886 |
NSC 734307 |
3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide |
0.00126952303154154 |
0.34184817 |
NSC 752464 |
methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate |
0.00126952303154154 |
0.29780789 |
NSC 757113 |
METHOTREXATE(+/-) |
0.00126952303154154 |
0.40126147 |
NSC 677249 |
Null |
0.00131875202369341 |
0.41194041 |
NSC 144173 |
Quinoxaline, 2,3-bis(iodomethyl)-6-methoxy- |
0.00131875202369342 |
0.53218654 |